Managing nicotine without smoke to save lives now: Evidence for harm minimization

Preventive Medicine

Volumn 117, Issue , 2018, Pages 88-97

  Abrams, David B ^a   Glasser, Allison M ^a   Villanti, Andrea C ^b   Pearson, Jennifer L ^c   Rose, Shyanika ^d   Niaura, Raymond S ^a  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d American Legacy Foundation   (United States)

Author keywords

Electronic nicotine delivery systems; Harm minimization; Harm reduction; Mortality; Nicotine; Non combusted tobacco; Public health impact; Smoking; Tobacco

Indexed keywords

CIGARETTE SMOKE; NICOTINE; NONCOMBUSTIBLE NICOTINE PRODUCT; UNCLASSIFIED DRUG;

ADOLESCENT SMOKING; ARTICLE; COMBUSTION; HARM REDUCTION; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; MEDICAL INFORMATION; MORTALITY; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE; VAPING; ELECTRONIC CIGARETTE; PROCEDURES; PSYCHOLOGY;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HARM REDUCTION; HUMANS; NICOTINE; SMOKERS; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS;

EID: 85049998497     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2018.06.010     Document Type: Article

References (145)

1. Abrams, D.B., Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete?. JAMA 311:2 (2014), 135–136.
2. Abrams, D.B., Potential and pitfalls of e-cigarettes—reply. JAMA 311:18 (2014), 1922–1923.
3. Abrams, D.B., Niaura, R., The importance of science-informed policy and what the data really tell us about e-cigarettes. Isr J Health Policy Res., 4, 2015, 22.
4. Abrams, D.B., Glasser, A.M., Villanti, A.C., Niaura, R., Cigarettes: the rise, decline but not the demise of the greatest behavioral health disaster of the 20th century. Kaplan, R., Spittel, M., David, D., (eds.) Emerging Behavioral and Social Science Perspectives on Population Health. Vol AHRQ Publication No. 15-0002, 2015, Agency for Healthcare Research and Quality, Office of Behavioral and Social Sciences Research, National Institutes of Health, Rockville, MD, 143–168.
5. Abrams, D.B., Glasser, A.M., Pearson, J.L., Villanti, A.C., Collins, L.K., Niaura, R.S., Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu. Rev. Public Health 39 (2018), 193–213.
6. Adriaens, K., Van Gucht, D., Declerck, P., Baeyens, F., Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int. J. Environ. Res. Public Health 11:11 (2014), 11220–11248.
7. Amato, M.S., Boyle, R.G., Levy, D., How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob. Control. 25:e1 (2016), e24–e29.
8. Ashley, D.L., Backinger, C.L., van Bemmel, D.M., Neveleff, D.J., Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products. Nicotine Tob. Res. 16:8 (2014), 1045–1049.
9. Babb, S., Malarcher, A., Schauer, G., Asman, K., Jamal, A., Quitting smoking among adults - United States, 2000–2015. MMWR Morb. Mortal. Wkly Rep. 65:52 (2017), 1457–1464.
10. Bachand, A.M., Sulsky, S.I., Curtin, G.M., Assessing the likelihood and magnitude of a population health benefit following the market introduction of a modified-risk tobacco product: enhancements to the dynamic population modeler, DPM(+1). Risk Anal. 38:1 (2018), 151–162.
11. Bacon, F., The New Organon and Related Writings. 1960, Liberal Arts Press, New York, NY.
12. Baicker, K., Chandra, A., Evidence-based health policy. N. Engl. J. Med. 377:25 (2017), 2413–2415.
13. Barrington-Trimis, J.L., Urman, R., Berhane, K., et al. E-cigarettes and future cigarette use. Pediatrics, 138(1), 2016.
14. Bauld, L., The Evidence Keeps Piling up: E-cigarettes are Definitely Safer than Smoking. https://www.theguardian.com/science/sifting-the-evidence/2017/dec/29/e-cigarettes-vaping-safer-than-smoking, 2017. (Accessed 16 January 2018)
15. Beard, E., Shahab, L., Cummings, D.M., Michie, S., West, R., New pharmacological agents to aid smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline?. CNS drugs 30:10 (2016), 951–983.
16. Benowitz, N.L., Re: Vaporised Nicotine Products Bill 2017. Letter to Senate Community Affairs Legislation Committee. 2017.
17. Benowitz, N.L., Burbank, A.D., Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc. Med. 26:6 (2016), 515–523.
18. Benowitz, N.L., Fraiman, J.B., Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 14:8 (2017), 447–456.
19. Benowitz, N.L., Donny, E.C., Hatsukami, D.K., Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game. Addiction 112:1 (2017), 6–7.
20. Biener, L., Hargraves, J.L., A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob. Res. 17:2 (2015), 127–133.
21. Birge, M., Duffy, S., Miler, J.A., Hajek, P., What proportion of people who try one cigarette become daily smokers? A meta analysis of representative surveys. Nicotine Tob. Res., 2017, 10.1093/ntr/ntx243.
22. Brandt, A.M., The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product that Defined America. 2007, Basic Books, New York, NY.
23. Britton, J., Bogdanovica, I., McNeill, A., Bauld, L., Commentary on WHO Report on Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems. http://ukctas.net/pdfs/UKCTAS-response-to-WHO-ENDS-report-26.10.2016.pdf, 2016. (Accessed 31 May 2017)
24. Brose, L.S., Hitchman, S.C., Brown, J., West, R., McNeill, A., Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 110:7 (2015), 1160–1168.
25. Brose, L.S., Brown, J., Hitchman, S.C., McNeill, A., Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug Alcohol Depend. 157 (2015), 106–111.
26. Bullen, C., Howe, C., Laugesen, M., et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382:9905 (2013), 1629–1637.
27. Caponnetto, P., Campagna, D., Cibella, F., et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8(6), 2013, e66317.
28. Caraballo, R.S., Shafer, P.R., Patel, D., Davis, K.C., McAfee, T.A., Quit methods used by US adult cigarette smokers, 2014–2016. Prev. Chronic Dis., 14, 2017, E32.
29. Centers for Disease Control and Prevention, Smoking & Tobacco Use: Fast Facts - Diseases and Death. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm, 2017. (Accessed 16 January 2018)
30. Chaloupka, F.J., Sweanor, D., Warner, K.E., Differential taxes for differential risks—toward reduced harm from nicotine-yielding products. N. Engl. J. Med. 373:7 (2015), 594–597.
31. Cherng, S.T., Tam, J., Christine, P.J., Meza, R., Modeling the effects of e-cigarettes on smoking behavior: implications for future adult smoking prevalence. Epidimiology 27:6 (2016), 819–826.
32. Cobb, N.K., Abrams, D.B., The FDA, e-cigarettes, and the demise of combusted tobacco. N. Engl. J. Med. 371:16 (2014), 1469–1471.
33. Cobb, C.O., Villanti, A.C., Graham, A.L., et al. Markov modeling to estimate the population impact of emerging tobacco products: a proof-of-concept study. Tob. Regul. Sci. 1:2 (2015), 121–141.
34. Colby, S.M., Clark, M.A., Rogers, M.L., et al. Development and reliability of the lifetime interview on smoking trajectories. Nicotine Tob. Res. 14:3 (2012), 290–298.
35. Collins, L.K., Villanti, A.C., Pearson, J.L., et al. Frequency of youth e-cigarette, tobacco, and poly-use in the United States, 2015: update to Villanti et al., “frequency of youth e-cigarette and tobacco use patterns in the United States: measurement precision is critical to inform public health”. Nicotine Tob. Res. 19:10 (2017), 1253–1254.
36. Delnevo, C.D., Giovenco, D.P., Steinberg, M.B., et al. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob. Res. 18:5 (2016), 715–719.
37. Donny, E.C., Denlinger, R.L., Tidey, J.W., et al. Randomized trial of reduced-nicotine standards for cigarettes. N. Engl. J. Med. 373:14 (2015), 1340–1349.
38. Fagerstrom, K.O., Bridgman, K., Tobacco harm reduction: the need for new products that can compete with cigarettes. Addict. Behav. 39:3 (2014), 507–511.
39. Fagerstrom, K., Etter, J.F., Unger, J.B., E-cigarettes: a disruptive technology that revolutionizes our field?. Nicotine Tob. Res. 17:2 (2015), 125–126.
40. Fairchild, A.L., Bayer, R., Colgrove, J., The renormalization of smoking? E-cigarettes and the tobacco “endgame”. N. Engl. J. Med. 370:4 (2014), 293–295.
41. Fairchild, A., Niaura, R., Abrams, D.B., America Needs a Candid Smoking Control Champion. http://thehill.com/opinion/healthcare/360111-america-needs-a-candid-smoking-control-champion, 2017. (Accessed 11 January 2017)
42. Fairchild, A.L., Lee, J.S., Bayer, R., Curran, J., E-cigarettes and the harm-reduction continuum. N. Engl. J. Med. 378:3 (2018), 216–219.
43. Farsalinos, K., Electronic cigarettes: an aid in smoking cessation, or a new health hazard?. Ther. Adv. Respir. Dis., 1753465817744960, 2017.
44. Farsalinos, K.E., Gilman, G., Carbonyl emissions in e-cigarette aerosol: a systematic review and methodological considerations. Front. Physiol., 8, 2018, 1119.
45. Farsalinos, K.E., Polosa, R., Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther. Adv. Drug Saf. 5:2 (2014), 67–86.
46. Farsalinos, K.E., Romagna, G., Tsiapras, D., Kyrzopoulos, S., Spyrou, A., Voudris, V., Impact of flavour variability on electronic cigarette use experience: an internet survey. Int. J. Environ. Res. Public Health 10:12 (2013), 7272–7282.
47. Farsalinos, K.E., Voudris, V., Poulas, K., E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction 110:8 (2015), 1352–1356.
48. Farsalinos, K.E., Poulas, K., Voudris, V., Le Houezec, J., Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey. Intern. Emerg. Med. 12:6 (2017), 757–763.
49. Fucito, L.M., Bars, M.P., Forray, A., et al. Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the association for the treatment of tobacco use and dependence and the society for research on nicotine and tobacco. Nicotine Tob. Res. 16:7 (2014), 909–914.
50. Giovenco, D.P., Delnevo, C.D., Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addict. Behav. 76 (2018), 129–134.
51. Gitchell, J.G., Shiffman, S., Sembower, M.A., Trends in serious quit attempts in the United States, 2009–14. Addiction 112:5 (2017), 897–900.
52. Glantz, S., Bareham, D., E-cigarettes: use, effects on smoking, risks, and policy implications. Annu. Rev. Public Health, 39, 2018 (28.21-28.21).
53. Glantz, S.A., Bareham, D.W., E-cigarettes: use, effects on smoking, risks, and policy implications. Annu. Rev. Public Health 39 (2018), 215–235.
54. Glasser, A.M., Collins, L., Pearson, J.L., et al. Overview of electronic nicotine delivery systems: a systematic review. Am. J. Prev. Med. 52:2 (2017), e33–e66.
55. Goniewicz, M.L., Knysak, J., Gawron, M., et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control. 23:2 (2014), 133–139.
56. Goniewicz, M.L., Gawron, M., Smith, D.M., Peng, M., Jacob, P. 3rd, Benowitz, N.L., Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob. Res. 19:2 (2017), 160–167.
57. Gottlieb, S., Zeller, M., A nicotine-focused framework for public health. N. Engl. J. Med. 377:12 (2017), 1111–1114.
58. Gucht, D.V., Adriaens, K., Baeyens, F., Online vape shop customers who use e-cigarettes report abstinence from smoking and improved quality of life, but a substantial minority still have vaping-related health concerns. Int. J. Environ. Res. Public Health, 14(7), 2017.
59. Hair, E., Bennett, M., Williams, V., et al. Progression to established patterns of cigarette smoking among young adults. Drug Alcohol Depend. 177 (2017), 77–83.
60. Hammond, D., McDonald, P.W., Fong, G.T., Borland, R., Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction 99:8 (2004), 1042–1048.
61. Harm Reduction International, What is harm reduction?. https://www.hri.global/what-is-harm-reduction. (Accessed 10 May 2017)
62. Hecht, S.S., Carmella, S.G., Kotandeniya, D., et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob. Res. 17:6 (2015), 704–709.
63. Heishman, S.J., Kleykamp, B.A., Singleton, E.G., Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology 210:4 (2010), 453–469.
64. Hitchman, S.C., Brose, L.S., Brown, J., Robson, D., Mcneill, A., Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob. Res. 17:10 (2015), 1187–1194.
65. Huerta, T.R., Walker, D.M., Mullen, D., Johnson, T.J., Ford, E.W., Trends in e-cigarette awareness and perceived harmfulness in the U.S. Am. J. Prev. Med. 52:3 (2017), 339–346.
66. Huh, J., Leventhal, A.M., Progression of poly-tobacco product use patterns in adolescents. Am. J. Prev. Med. 51:4 (2016), 513–517.
67. Kalkhoran, S., Glantz, S.A., Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: a Monte Carlo analysis. JAMA Intern. Med. 175:10 (2015), 1671–1680.
68. Kalkhoran, S., Glantz, S.A., E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir. Med. 4:2 (2016), 116–128.
69. Kingdon, J.W., Agendas, Alternatives, and Public Policies. 2003, Addison-Wesley Educational Publishers, Inc., New York, NY.
70. Kirchner, T.R., Shiffman, S., Spatio-temporal determinants of mental health and well-being: advances in geographically-explicit ecological momentary assessment (GEMA). Soc. Psychiatry Psychiatr. Epidemiol. 51:9 (2016), 1211–1223.
71. Kozlowski, L.T., Abrams, D.B., Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction. BMC Public Health, 16(1), 2016, 432.
72. Kozlowski, L.T., Edwards, B.Q., “Not safe” is not enough: smokers have a right to know more than there is no safe tobacco product. Tob. Control. 14:Suppl. 2 (2005), ii3–7.
73. Kozlowski, L., Giovino, G., Softening of monthly cigarette use in youth and the need to harden measures in surveillance. Prev. Med. Rep. 1 (2014), 53–55.
74. Kozlowski, L.T., O'Connor, R.J., Apply federal research rules on deception to misleading health information: an example on smokeless tobacco and cigarettes. Public Health Rep. 118:3 (2003), 187–192.
75. Kozlowski, L.T., Sweanor, D., Withholding differential risk information on legal consumer nicotine/tobacco products: the public health ethics of health information quarantines. Int. J. Drug Policy 32 (2016), 17–23.
76. Kozlowski, L.T., Warner, K.E., Adolescents and e-cigarettes: objects of concern may appear larger than they are. Drug Alcohol Depend. 174 (2017), 209–214.
77. Kozlowski, L.T., Strasser, A.A., Giovino, G.A., Erickson, P.A., Terza, J.V., Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob. Control. 10:3 (2001), 201–203.
78. Kuhn, T.S., The Structure of Scientific Revolutions: 50th Anniversary Edition. Fourth ed., 2012, University of Chicago Press, Chicago, IL.
79. Lee, P.N., Epidemiological evidence relating snus to health—an updated review based on recent publications. Harm Reduct J., 10, 2013, 36.
80. Lee, P.N., Hamling, J., Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med., 7, 2009, 36.
81. Leventhal, A.M., Strong, D.R., Kirkpatrick, M.G., et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 314:7 (2015), 700–707.
82. Leventhal, A.M., Stone, M.D., Andrabi, N., et al. Association of e-cigarette vaping and progression to heavier patterns of cigarette smoking. JAMA 316:18 (2016), 1918–1920.
83. Levy, D.T., Borland, R., Villanti, A.C., et al. The application of a decision-theoretic model to estimate the public health impact of vaporized nicotine product initiation in the United States. Nicotine Tob. Res. 19:2 (2017), 149–159.
84. Levy, D.T., Yuan, Z., Luo, Y., Abrams, D.B., The relationship of e-cigarette use to cigarette quit attempts and cessation: insights from a large, nationally representative U.S. survey. Nicotine Tob. Res., 2017, 10.1093/ntr/ntx166.
85. Levy, D.T., Cummings, K.M., Villanti, A.C., et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction 112:1 (2017), 8–17.
86. Levy, D.T., Borland, R., Fong, G.T., et al. Developing consistent and transparent models of e-cigarette use: reply to Glantz and Soneji et al. Nicotine Tob. Res. 19:2 (2017), 268–270.
87. Levy, D.T., Borland, R., Lindblom, E.N., et al. Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tob. Control. 27:1 (2018), 18–25.
88. Majeed, B.A., Weaver, S.R., Gregory, K.R., et al. Changing perceptions of harm of e-cigarettes among U.S. adults, 2012–2015. Am. J. Prev. Med. 52:3 (2017), 331–338.
89. Manzoli, L., Flacco, M.E., Fiore, M., et al. Electronic cigarettes efficacy and safety at 12 months: cohort study. PLoS One, 10(6), 2015, e0129443.
90. McNeill, A., Brose, L.S., Calder, R., Hitchman, S., Hajek, P., McRobbie, H., E-Cigarettes: An Evidence Update — A Report Commissioned by Public Health England. 2015, Public Health England, London, England.
91. McNeill, A., Brose, L.S., Calder, R., Bauld, L., Robson, D., Evidence Review of E-cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England. 2018, Public Health England, London.
92. McRobbie, H., Bullen, C., Hartmann-Boyce, J., Hajek, P., Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst. Rev., 12, 2014, Cd010216.
93. Miech, R., Patrick, M.E., O'Malley, P.M., Johnston, L.D., E-cigarette use as a predictor of cigarette smoking: results from a 1-year follow-up of a national sample of 12th grade students. Tob. Control. 26:e2 (2017), e106–e111.
94. Miller, T., AG Tom Miller - E-Cigarette Summit 2016. https://vimeo.com/199643660, 2016. (Accessed 11 January 2018)
95. National Academies of Sciences Engineering, and Medicine, Public Health Consequences of E-cigarettes. 2018, The National Academies Press, Washington, DC.
96. National Cancer Institute, Health Information National Trends Survey: compared to smoking cigarettes, would you say that electronic cigarettes are…. https://hints.cancer.gov/question-details.aspx?PK_Cycle=8&qid=1282, 2015. (Accessed 31 May 2017)
97. Niaura, R., Re-thinking Nicotine and its Effects. https://truthinitiative.org/sites/default/files/ReThinking-Nicotine.pdf, 2016.
98. Niaura, R.S., Glynn, T.J., Abrams, D.B., Youth experimentation with e-cigarettes: another interpretation of the data. JAMA Pediatr. 312:6 (2014), 1–2.
99. Nutt, D.J., Phillips, L.D., Balfour, D., et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur. Addict. Res. 20:5 (2014), 218–225.
100. O'Brien, B., Knight-West, O., Walker, N., Parag, V., Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tob. Induc. Dis., 13(1), 2015, 5.
101. O'Leary, R., MacDonald, M., Stockwell, T., Reist, D., Clearing the Air: A Systematic Review on the Harms and Benefits of E-cigarettes and Vapour Devices. 2017, University of Victoria Centre for Addictions Research of BC, Victoria, British Columbia.
102. Parks, S.H., Duncan, D.T., Shahawy, O.E., et al. Characteristics of adults who switched from cigarette smoking to e-cigarettes. Am. J. Prev. Med. 53:5 (2017), 652–660.
103. Pechacek, T.F., Nayak, P., Gregory, K.R., Weaver, S.R., Eriksen, M.P., The potential that electronic nicotine delivery systems can be a disruptive technology: results from a national survey. Nicotine Tob. Res. 18:10 (2016), 1989–1997.
104. Primack, B.A., Soneji, S., Stoolmiller, M., Fine, M.J., Sargent, J.D., Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr. 169:11 (2015), 1018–1023.
105. Proctor, R.N., Golden holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition. 2011, University of California Press, Oakland, CA.
106. Robson, D., McNeill, A., Answering the question or questioning the answer?. Addiction 113:3 (2017), 407–409.
107. Royal College Physicians, Nicotine Without Smoke: Tobacco Harm Reduction. (London April), 2016.
108. Russell, M.A., Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br. Med. J. 1:6023 (1976), 1430–1433.
109. Russell, C., McKeganey, N., Dickson, T., Nides, M., Changing patterns of first e-cigarette flavor used and current flabors used by 20,836 adult frequent e-cigarette users in the United States. Harm Reduct J., 15, 2018, 33, 10.1186/s12954-018-0238-6 (Published Online 28th June 2018).
110. Shahab, L., Goniewicz, M.L., Blount, B.C., et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann. Intern. Med. 166:6 (2017), 390–400.
111. Smiley, S.L., Deatley, T., Rubin, L.F., et al. Early subjective sensory experiences with “cigalike” e-cigarettes among African American menthol smokers: a qualitative study. Nicotine Tob. Res., 2017, 10.1093/ntr/ntx102.
112. Soneji, S., Errors in data input in meta-analysis on association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults. JAMA Pediatr. 172:1 (2018), 92–93.
113. Soneji, S., Barrington-Trimis, J.L., Wills, T.A., et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 171:8 (2017), 788–797.
114. Soneji, S.S., Sung, H.Y., Primack, B.A., Pierce, J.P., Sargent, J.D., Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One, 13(3), 2018, e0193328.
115. Spindle, T.R., Hiler, M.M., Cooke, M.E., Eissenberg, T., Kendler, K.S., Dick, D.M., Electronic cigarette use and uptake of cigarette smoking: a longitudinal examination of U.S. college students. Addict. Behav. 67 (2017), 66–72.
116. Stephens, W.E., Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob. Control., 2017, 10.1136/tobaccocontrol-2017-053808.
117. Talati, A., Keyes, K.M., Hasin, D.S., Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications. Mol. Psychiatry 21:4 (2016), 464–471.
118. The Cochrane Handbook for Systematic Reviews of Interventions, Vol Version 5.1.0, 2011, John Wiley & Sons Ltd, West Sussex, England.
119. Tobacco Products Scientific Advisory Committee, Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations. 2011, U.S. Food and Drug Administration, Center for Tobacco Products, Rockville, MD.
120. Tobacco Use and Dependence Guideline Panel, Treating Tobacco Use and Dependence: 2008 Update. 2008, US Department of Health and Human Services, Rockville (MD).
121. Tseng, T.Y., Ostroff, J.S., Campo, A., et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob. Res. 18:10 (2016), 1937–1943.
122. U.S. Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
123. U.S. Department of Health and Human Services, E-cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. 2016, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
124. U.S. Food and Drug Administration. Division A—family smoking prevention and tobacco control act. In: Department of Health and Human Services US, ed. Public Law 111–31. Vol 12562009.
125. Vanyukov, M.M., Tarter, R.E., Kirillova, G.P., et al. Common liability to addiction and “gateway hypothesis”: theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 123:Suppl. 1 (2012), S3–17.
126. Villanti, A.C., Giovino, G.A., Burns, D.M., Abrams, D.B., Menthol cigarettes and mortality: keeping focus on the public health standard. Nicotine Tob. Res. 15:2 (2013), 617–618.
127. Villanti, A.C., Pearson, J.L., Glasser, A.M., et al. Frequency of youth e-cigarette and tobacco use patterns in the U.S.: measurement precision is critical to inform public health. Nicotine Tob. Res. 19:11 (2016), 1345–1350.
128. Villanti, A.C., Feirman, S.P., Niaura, R.S., et al. How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor. Addiction 113:3 (2017), 391–404.
129. Villanti, A.C., Johnson, A.L., Ambrose, B.K., et al. Flavored tobacco product use in youth and adults: findings from the first wave of the PATH study (2013–2014). Am. J. Prev. Med. 53:2 (2017), 139–151.
130. Vugrin, E.D., Rostron, B.L., Verzi, S.J., et al. Modeling the potential effects of new tobacco products and policies: a dynamic population model for multiple product use and harm. PLoS One, 10(3), 2015, e0121008.
131. Warner, K.E., An endgame for tobacco?. Tob. Control. 22:Suppl. 1 (2013), i3–i5.
132. Warner, K.E., How to think - not feel - about tobacco harm reduction. Nicotine Tob. Res., 2018, 10.1093/ntr/nty084.
133. Warner, K.E., Mendez, D., E-cigarettes: comparing the possible risks of increasing smoking initiation with the potential benefits of increasing smoking cessation. Nicotine Tob. Res., 2018, 10.1093/ntr/nty062.
134. West, R., Improving the quality of research on e-cigarettes. The E-cigarette Summit, 2017 November 17. (London, England).
135. West, R., Hajek, P., Foulds, J., Nilsson, F., May, S., Meadows, A., A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 149:3 (2000), 198–202.
136. West, R., Shahab, L., Brown, J., Estimating the population impact of e-cigarettes on smoking cessation in England. Addiction 111:6 (2016), 1118–1119.
137. West, R., Brown, J., Shahab, L., Written Evidence Submitted by University College London, Tobacco and Alcohol Research Group (UTARG) (ECG0047). 2017, UK Parliament (December 12).
138. Wills, T.A., Gibbons, F.X., Sargent, J.D., Schweitzer, R.J., How is the effect of adolescent e-cigarette use on smoking onset mediated: a longitudinal analysis. Psychol. Addict. Behav. 30:8 (2016), 876–886.
139. Wills, T.A., Sargent, J.D., Gibbons, F.X., Pagano, I., Schweitzer, R., E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tob. Control. 26:5 (2016), 534–539.
140. Wills, T.A., Knight, R., Sargent, J.D., Gibbons, F.X., Pagano, I., Williams, R.J., Longitudinal study of e-cigarette use and onset of cigarette smoking among high school students in Hawaii. Tob. Control. 26:1 (2017), 34–39.
141. Wipfli, H.L., Berman, M., Hanson, K., et al. Defining tobacco regulatory science competencies. Nicotine Tob. Res. 19:2 (2017), 222–230.
142. World Health Organization, WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. 2008, World Health Organization, Geneva, Switzerland.
143. World Health Organization, Tobacco Fact Sheet. http://www.who.int/mediacentre/factsheets/fs339/en/, 2017. (Accessed 9 August 2017)
144. Yach, D., Foundation for a smoke-free world. Lancet 390:10104 (2017), 1807–1810.
145. Zhu, S.H., Zhuang, Y.L., Wong, S., Cummins, S.E., Tedeschi, G.J., E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ, 358, 2017, j3262.